Company Overview of MPM Capital
MPM Capital is a private equity and venture capital firm specializing in seed, startup, early ventures, emerging growth, middle market, mature, mid venture, late venture, buyout, recapitalization, PIPES, and growth equity investments. The firm makes its venture investments through its MPM BioVentures fund and invests in the public markets through MPM BioEquities hedge fund. It invests in growth stage in in the biotechnology, healthcare, and life sciences sector. It invests in the seed stage through early clinical development stage of a company and invests in late stage in biopharmaceutical and diagnostics companies with clinical proof-of-concept data. It prefers to invest in medical technolo...
450 Kendall Street
Cambridge, MA 02142
Founded in 1996
Key Executives for MPM Capital
Co-Founder, Managing Director and Managing Partner
Managing Director and Co-Founder
Chief Operating Officer and General Counsel
Compensation as of Fiscal Year 2015.
MPM Capital Key Developments
MPM Capital Appoints Mitchell H. Finer PhD as Managing Director
Sep 15 15
MPM Capital announced the appointment of Mitchell H. Finer PhD (Mitch) as Managing Director (MD). Mitch also serves on the Board of Directors of MPM's portfolio company Semma Therapeutics Inc. Mitch's most recent role was as CSO of bluebird bio. Prior to bluebird, Dr. Finer served as Senior VP of Development and Operations for Novocell.
MPM Capital Presents at BioPharm America 2015, Sep-17-2015 10:30 AM
Jul 20 15
MPM Capital Presents at BioPharm America 2015, Sep-17-2015 10:30 AM. Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States. Speakers: Robert Millman, Managing Director.
MPM Capital Appoints Briggs W. Morrison, M.D. as Managing Director
Jun 22 15
MPM Capital announced the appointment of Briggs W. Morrison, M.D., to the position of Managing Director. Dr. Morrison was recently appointed Chief Executive Officer of Syndax Pharmaceuticals Inc., after serving as Chief Medical Officer and Executive Vice President for R&D at AstraZeneca.
Similar Private Companies By Industry
Recent Private Companies Transactions